Canopy Growth Corporation's (NYSE: CGC) (TSX: WEED) subsidiary, Canopy Growth Germany GmbH announced on Wednesday that the company is changing from Spectrum Therapeutics to Canopy Medical in the German market.
Why It Matters
The move will align the company's medical business with the corporate Canopy Growth brand.
Moreover, this alignment further reinforces Canopy Growth's commitment to long-term growth within the German medical cannabis market and unwavering commitment to German medical cannabis patients, the Canadian cannabis giant said in a press release.
Tara Rozalowsky, chief growth officer and president of international markets at Canopy Growth said the decision "represents a visual demonstration of our leadership position in this priority market, as well as Canopy Growth's growing strength within the international medical cannabis industry."
"Since then, my role has been …